I have been keeping a list of anthracycline cardioprotective drugs (in the lab anyway) and I have a list with over 200 of them. What none of them have is broad, additive/synergistic anticancer activity which is the key to commercial success. We already have had a cheap generic cardioprotective drug (dexrazoxane) on the market for decades and it is hardly ever used in patients because it doesn't help treat their cancer.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.025(2.08%) |
Mkt cap ! $204.1M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.17 | $130.6K | 109.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10250 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 2000 | 1 |
View Market Depth
| Last trade - 15.58pm 30/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |